A new study, led by experts at the University of Nottingham, has found that combining certain types of dietary supplements is more effective than single prebiotics or omega-3 in supporting immune and metabolic health, which could lower the risk of conditions linked to chronic inflammation.

The findings of the study, which are published in the Journal of Translational Medicine, show that a synbiotic - a combination of naturally fermented kefir and a diverse prebiotic fibre mix - produces the most powerful anti-inflammatory effects among the three common dietary supplements tested.

The kefir and prebiotic mix was provided by Chuckling Goat Ltd. It contains a mx of naturally occurring probiotic bacteria and yeasts, which form during the traditional fermentation of goat’s milk with live kefir grains. These grains are living cultures that house dozens of beneficial microbial species.

A UNLV-led team of researchers has co-opted a common kitchen spice to create a new class of cannabidiol (CBD)-like medicines that show powerful seizure-reducing effects — offering a safer, more affordable, and more effective treatment for childhood seizure disorders than existing frontline therapies. Caraway seeds — a seasoning commonly used in both savory and sweet dishes, and also known as meridian fennel — are the key ingredient behind researchers’ method.

A new breakthrough in a rare genetic disease which causes children to age rapidly has been discovered using ‘longevity genes’ found in people who live exceptionally long lives - over 100 years old. The research, by the University of Bristol and IRCCS MultiMedica, found these genes which helps keep the heart and blood vessels healthy during aging could reverse the damage caused by this life-limiting disease.

For patients with knee osteoarthritis, aerobic activities such as walking, cycling, or swimming are likely to be the best exercise for improving pain, function, gait performance, and quality of life, finds a study published by The BMJ today.

Imposter participants threaten the integrity of health research and, by extension, the policies and clinical decisions built on it, warn experts in The BMJ today.

Boston Children’s Hospital, along with Broad Clinical Labs and Roche Sequencing Solutions, has demonstrated that rapid genomic sequencing and interpretation are achievable in a matter of hours. This milestone not only sets a GUINNESS WORLD RECORDS™ for the fastest human whole genome sequencing to date but represents a significant clinical development that would expedite more precise treatments to critically ill babies in the NICU. The team’s pilot data was published today in New England Journal of Medicine.

A blood stem cell gene therapy co-developed by UCLA’s Dr. Donald Kohn restored immune function in 59 of 62 children with ADA-SCID, a rare and fatal immune disorder, with no serious complications reported. Without treatment, ADA-SCID is often fatal within the first two years of life, and current standard therapies — a stem cell transplant from a matched donor or lifelong enzyme injections — carry risks and high costs. The new study represents the largest and longest follow-up of a gene therapy of this kind, with 474 years of patient data including five children still healthy over a decade after receiving the treatment.